Stay updated on Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Napoli, Italy, 80131 was updated to Naples, Italy, 80131 in the Locations list.
    Difference
    0.0%
    Check dated 2026-03-25T20:33:51.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed, reflecting an update to the document's revision history.
    Difference
    0.0%
    Check dated 2026-03-18T16:48:58.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision labels were updated: 'Revision: v3.4.3' added and 'Revision: v3.4.2' removed.
    Difference
    0.0%
    Check dated 2026-03-11T14:12:38.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the conditions section, and the Genetic and Rare Diseases Information Center resource was added under Resources.
    Difference
    0.1%
    Check dated 2026-02-18T03:51:55.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    There is a new revision label 'Revision: v3.4.2' on the page and the previous notice about government funding status and operating updates has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:40:03.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-03T23:56:44.000Z thumbnail image

Stay in the know with updates to Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.